Diaphragm Paralysis: Surgery or Mechanical Ventialion
Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · Aug 24, 2021
Trial Information
Current as of July 06, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different treatments for patients with diaphragm paralysis, a condition where the diaphragm muscle, which helps you breathe, does not work properly. The trial will compare the effects of surgical plication (a procedure that tightens the diaphragm) and non-invasive ventilation (using a machine to help with breathing) on patients' quality of life. Researchers want to see how each treatment affects daily living and overall well-being, using a questionnaire and other assessments.
To participate in this study, you need to be over 18 years old and diagnosed with a unilateral diaphragm paralysis caused by an isolated injury to the phrenic nerve. This means you have breathing difficulties that worsen when lying down, and specific tests confirm your condition. If you join the study, you will be randomly assigned to either receive surgery or use a breathing machine at night while waiting for surgery. The trial is looking for a total of 20 participants, and it aims to gather important information that can help doctors make better treatment decisions for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years
- • diagnosed with a unilateral diaphragm paralysis based on isolated phrenic nerve injury.
- • Unilateral diaphragm paralysis is defined as follows: complaints of dyspnea and / or orthopnea combined with a drop in VC of more than 15% when change from upright to supine position and a positive sniff test during fluoroscopy or ultrasonography. A positive sniff test means that the diaphragm stands still or even moves in cranial direction (paradoxical movement ) during the sniff inspiratory maneuver.
- • Ability to provide written consent
- • Time between diagnosis and treatment should be at least 1 year
- Exclusion Criteria:
- • Patients diagnosed with a bilateral diaphragm paralysis.
- • A diaphragm paralysis in combination with a more systemic neurological or neuromuscular disorder like for example Amyotrophic Lateral Sclerosis ,
- • Hypercapnia during daytime (PaCO2 \> 6.0 kPa)
- • Radiotherapy of the thorax
- • Contra indication for diaphragm surgery.
About University Medical Center Groningen
University Medical Center Groningen (UMCG) is a leading academic medical center in the Netherlands, renowned for its commitment to innovative research, high-quality patient care, and extensive education in the medical field. As a prominent sponsor of clinical trials, UMCG leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve therapeutic outcomes. The center fosters collaboration among researchers, healthcare professionals, and industry partners, aiming to translate scientific discoveries into effective treatments that enhance patient health and well-being. With a focus on ethical standards and regulatory compliance, UMCG is dedicated to conducting clinical trials that contribute to the advancement of medicine and the betterment of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Groningen, , Netherlands
Groningen, , Netherlands
Patients applied
Trial Officials
Peter Wijkstra, prof
Principal Investigator
UMCG
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials